Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Meta-analysis of prevalence.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
SIRT1 is decreased during relapses in patients with multiple sclerosis.
Sphingolipids in neuroinflammation.
Sexual disparities in the incidence and course of MS.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.

Pages